These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17264454)

  • 1. Multicentric study of efficacy and safety of growth hormone use in growth hormone deficient children in India.
    Khadilkar VV; Khadilkar AV; Nandy M; Maskati GB
    Indian J Pediatr; 2007 Jan; 74(1):51-4. PubMed ID: 17264454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between growth response to growth hormone and baseline body composition of children with growth hormone deficiency.
    Esen I; Demirel F; Tepe D; Kara O; Koc N
    Growth Horm IGF Res; 2013 Oct; 23(5):196-9. PubMed ID: 23890535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effect of two doses of growth hormone for growth hormone deficiency. The Dutch Growth Hormone Working Group.
    De Muinck Keizer-Schrama S; Rikken B; Hokken-Koelega A; Wit JM; Drop S
    Arch Dis Child; 1994 Jul; 71(1):12-8. PubMed ID: 8067786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone in turner syndrome.
    Khadilkar VV; Khadilkar AV; Nandy M; Maskati GB
    Indian Pediatr; 2006 Mar; 43(3):236-40. PubMed ID: 16585818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone for children with chronic kidney disease.
    Hodson EM; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD003264. PubMed ID: 22336787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthetic human growth hormone in the treatment of growth hormone deficiency.
    Holcombe JH; Conforti PM; Wong AC; Thompson RG; Draper MW
    Acta Paediatr Scand Suppl; 1990; 367():44-8. PubMed ID: 2220388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board.
    Cutfield W; Lindberg A; Albertsson Wikland K; Chatelain P; Ranke MB; Wilton P
    Acta Paediatr Suppl; 1999 Feb; 88(428):72-5. PubMed ID: 10102057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of long-term recombinant growth hormone therapy in children--the National Cooperative Growth Study, USA, 1985-1994.
    Root AW; Kemp SF; Rundle AC; Dana K; Attie KM
    J Pediatr Endocrinol Metab; 1998; 11(3):403-12. PubMed ID: 11517956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recombinant human growth hormone treatment in short children with renal disease--our first experience].
    Spasojević-Dimitrijeva B; Kostić M; Peco-Antić A; Kruscić D; Cvetković M; Milosevski-Lomić G; Paripović D
    Srp Arh Celok Lek; 2010; 138(3-4):197-203. PubMed ID: 20499500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
    Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.
    Cavallo L; Gurrado R; Zecchino C; Manolo F; De Sanctis V; Cisternino M; Caruso-Nicoletti M; Galati M
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():845-9. PubMed ID: 10091155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary response in GHD children treatment as a predictor for long-term therapy effectiveness therapy effectiveness.
    Kapała JM; Maroszczuk T; Sitarz A; Kącka A; Charemska D
    Pediatr Endocrinol Diabetes Metab; 2024; 30(2):61-68. PubMed ID: 39026482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A follow-up study to monitor adult height among Spanish children with growth hormone deficiency who received biosimilar human recombinant growth hormone (Omnitrope®) during a phase III clinical trial.
    Borrás Pérez V; López-Siguero JP; Martínez G; Corripio R; Fernández JM; Labarta JI; Ferrer M; Cabrinety N; Prieto P; Ramón-Krauel M; Bosch J; Espino R; Palla Garcia M; Rebollo FJ
    Adv Ther; 2015 Feb; 32(2):148-56. PubMed ID: 25667132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children.
    Hou L; Liang Y; Wu W; Lin HH; Luo XP; Ying YQ
    Growth Horm IGF Res; 2020; 53-54():101331. PubMed ID: 32777706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase inhibitors: a useful additional therapeutic option for slowing down advanced bone age in boys with growth hormone deficiency.
    Akın Kağızmanlı G; Özalp Kızılay D; Besci Ö; Yüksek Acinikli K; Özen S; Demir K; Gökşen Şimşek RD; Böber E; Darcan Ş; Abacı A
    J Endocrinol Invest; 2024 May; 47(5):1227-1235. PubMed ID: 38040920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Effectiveness and Comparable Safety in Biweekly
    Sun C; Lu B; Liu Y; Zhang Y; Wei H; Hu X; Hu P; Zhao Q; Liu Y; Ye K; Wang K; Gu Z; Liu Z; Ye J; Zhang H; Zhu H; Jiang Z; Liu Y; Wan N; Yan C; Yin J; Ying L; Huang F; Yin Q; Xi L; Luo F; Cheng R
    Front Endocrinol (Lausanne); 2021; 12():779365. PubMed ID: 34899612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone.
    Westphal O; Lindberg A;
    Acta Paediatr; 2008 Dec; 97(12):1698-706. PubMed ID: 18976357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.